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Abstract 
Polymeric nanoparticles (NPs) of poly(-caprolactone) (PCL) covered with a hydrophilic 
poly(ethylene glycol) (PEG) shell are usually prepared from diblock PEG-PCL copolymers through 
different techniques. Beside PEG, NPs can be decorated with targeting ligands to accumulate in specific 
cell lines. However, the density and conformation of PEG on the surface and its impact on the exposition 
of small targeting ligands has been poorly considered so far although this has a huge impact on biological 
behavior. Here, we focus on PEG-PCL NPs and their folate-targeted version to encourage accumulation 
in cancer cells overexpressing folate receptor α. NPs were prepared with mixtures of PEG-PCL with 
different PEG length (short 1.0 kDa, long 2.0 kDa,) and a folate-functionalized PEG-PCL (PEG 1.5 kDa) 
by the widely employed solvent displacement method. In depth characterization of NPs surface by 
1
H 
NMR, fluorescence and photon correlation spectroscopy evidenced a PEGylation extent below 7% with 
PEG in a mushroom conformation and the presence of folate more exposed to water pool in the case of 
copolymer with short PEG. NPs with short PEG adsorbed HSA forming a soft corona without 
aggregating. Although limited, PEGylation overall reduced NPs uptake in human macrophages. Uptake of 
NPs exposing folate prepared with short PEG was higher in KB cells (FR+) than in A549 (FR-), occurred 
via FR-receptor and involved lipid rafts-dependent endocytosis.  In conclusion, the present results 
demonstrate that PEG length critically affects protein interaction and folate exposition with a logical 
impact on receptor-mediated cell uptake. Our study highlights that the too simplistic view suggesting that 
PEG-PCL gives PEG-coated NPs needs to be re-examined in the light of actual surface properties, which 
should always be considered case-by-case. 
 
 
  
1 Introduction 
Polymeric nanoparticles (NPs) are in the limelight in cancer nanotechnology due to the advantages of 
prompt manipulation of the overall features (size, surface hydrophilicity/charge, release rate, 
biodegradability) through appropriate tailoring of the chemistry of building blocks (Grossen et al., 2017). 
Amid the huge amount of biomaterials developed so far, poly(ε-caprolactone)-poly(ethylene glycol) PEG-
PCL copolymers with different hydrophilic/lipophilic balance and architectures have been synthesized 
resulting in a wide arsenal for drug delivery application (Li and Tan, 2014). In the context of cancer 
therapies, NPs of PEG-PCL block copolymers have gained attention in preclinical studies and in clinical 
settings with the promise to ameliorate chemotherapy outcome and decrease treatment toxicity. As far as 
PEG-PCL NPs for intravenous injection are concerned, a PEGylated surface can help to escape 
mononuclear phagocyte system, to attain long-circulation and to promote extravasation in inflamed 
tissues with a typical dysfunctional capillary bed such as in tumors (Bertrand and Leroux, 2012). While 
demonstrating excellent stability in PBS, PEG-PCL NPs were even found to aggregate in the presence of 
serum (Gao et al., 2014).  
Surface modification of PEGylated NPs with covalently-linked small ligands is a further strategy 
followed to increase drug level in cancer cells. To this purpose, the design of folate-decorated NPs 
carrying a chemotherapeutic and internalizing in cancer cells through FRα-mediated endocytosis has 
become a hot topic (Cheung et al., 2016). FRα expression level is a marker of tumor aggressiveness, plays 
a role in the low response rate to chemotherapeutics resistance and is insensitive to chemotherapy 
regimen (Cheung et al., 2016), thus strengthening the potential utility of FR-mediated delivery.  Folate 
decoration of PEG-PCL NPs has been attempted by us and other authors by synthesizing all-in-one 
amphiphilic block copolymers bearing folate at PEG hydroxyl-end group and able to form core-shell NPs 
(Grossen et al., 2017). When the amphiphilic diblock polymers self-assemble into NPs in an aqueous 
phase, the PEG segments are expected to form the outer corona allowing the conjugated folic acid to 
become fully accessible on the surface. In contrast to this paradigm, we observed that for highly 
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PEGylated micelle-like NPs, folate exposition in the presence of serum is highly dependent by the 
formation of a protein corona (Conte et al., 2016).  
Another aspect to consider when fabricating PEG-PCL NPs refers to the mode of copolymer assembly. 
While dialysis has been largely employed to prepare PEG-PCL micelles/NPs, scale-up of production as 
well as in-process sterilization is feasible with microfluidics which takes after solvent displacement 
(nanoprecipitation) techniques. Importantly, mode of assembly of PEG-PCL copolymers can highly affect 
the amount of PEG on the surface (Quaglia et al., 2006) while its impact on protein adsorption and 
targeting features has been poorly considered.  
On this basis, it is evident that PEG coverage plays a crucial role in controlling the biological fate of 
PEGylated NPs with an huge impact on the processes driven by protein interactions (immune system 
recognition, biodistribution), transport through biological matrices (tumor extracellular matrix, mucus, 
bacteria biofilm), and target recognition and docking (cell uptake) (Rabanel et al., 2014). Despite the 
extensive use of PEG, there is no consensus on the target product profile in term of PEG density, 
molecular weight and conformation when developing PEGylated NPs intended for a specific application, 
in cancer as well (Owens and Peppas, 2006). Thus, surface of NPs should be characterized in depth 
through complimentary techniques in view of a full optimization of the nanocarrier and following clinical 
application (Rabanel et al., 2014). 
In this study, we try to shed light on the surface exposition of PEG and folate targeting units on NPs of 
PEG-PCL diblock copolymers prepared by solvent displacement technique and to relate shell features to 
uptake in human cells. To this purpose, we synthesized PEG-PCL copolymers with either 1 kDa or 2 kDa 
PEG chains and a Fol-PEG-PCL copolymers with 1.5 kDa PEG segment. Shell properties of untargeted 
and folate-targeted NPs were fully characterized through complementary techniques, such as 
1
H NMR, 
fluorescence, photon correlation spectroscopy and ξ potential. The impact of shell features on NPs 
interaction with human serum albumin, stability in biologically-relevant media as well as internalization 
in human macrophages and cancer cells overexpressing folate receptor were investigated. 
 2 Experimental section 
2.1 Materials 
 Poly(ethylene glycol) (PEG) with Mn 1.5 kDa (PEG1.5k, Sigma-Aldrich, Milan, Italy), 
monomethoxy-poly(ethylene glycol) with Mn 2.0 kDa (mPEGL, Sigma-Aldrich, Italy) and 
monomethoxy-poly(ethylene glycol) with Mn 1.0 kDa (mPEGS, Nanocs Inc., USA) were dehydrated by 
azeotropic distillation with dry toluene in a Dean-Stark trap. ε-Caprolactone (CL, Sigma-Aldrich, Italy) 
was distilled over CaH2 under vacuum. Stannous-(2-ethylhexanoate)2 (Sn(oct)2), N-hydroxysuccinimide 
(NHS), N,N′-dicyclohexylcarbodiimide (DCC), triethylamine (TEA), dimethylaminopyridine (DMAP), 
tosyl chloride (TsCl), folic acid (Fol), propargylamine, triphenylphosphine (PPh3), silver(I) oxide, 
potassium iodide and sodium azide were used without further purification. Copper wires (Carlo Erba, 
Italy) were treated with H2S04 for 3 min, washed with water and methanol, and finally dried under 
vacuum in an oven for 30 minutes at 60°C. 1,4-butandiol, 1-hexanol, N,N-dimethylformamide (DMF) 
and dichloromethane (DCM) were dried before use according to standard procedures. All the other 
solvents (analytical grade) were purchased from Sigma-Aldrich and used as received. (2-Hydroxypropyl)-
β-cyclodextrin (HPβCD, DS 0.9), Nile Red (NR) and Human Serum Albumin (HSA) were from Sigma 
(Italy). 
2.2 Copolymer characterization 
FTIR analysis was performed with a Perkin-Elmer spectrometer (Paragon 500) equipped with a ZnSe 
attenuated total reflectance (ATR) crystal accessory. Samples were placed in direct contact with the ATR 
crystal and pressed with a pressure clamp positioned over the crystal/sample area to allow intimate 
contact between the material and the crystal. Spectra were acquired in the 4000-400 cm
-1
 range, at a 
resolution of 2 cm
-1
 (average of 20 scans). 
1
H NMR analysis, spectra were recorded with a Bruker Avance 
DPX400 apparatus operating at 400 MHz. For GPC analysis, samples were dissolved in THF and passed 
through a 0.22 μm PTFE membrane filter. Measurements were performed on an injected volume of 100 
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μL by using a Malvern-Viscotek GPC MAX/TDA 305 quadruple detector array equipped with a 
precolumn and two Phenogel columns (Phenomenex) with exclusion limits 10
6
 and 10
3
 respectively. The 
GPC instrument was used at a flow rate of 0.8 mL/min and at columns and system temperature of 35 °C. 
Triple detectors calibration was based on a standard of polystyrene with molecular weight 104,959 Da. 
Residual copper content was estimated by Microwave Plasma-Atomic Emission Spectrometry (MP-AES) 
with a Agilent 4100 spectrometer. A microwave digestion system Milestone Ethos Touch Control was 
used for digestion of sample. The finely ground sample (0.1 g) was transferred in a teflon microwave 
digestion vessel and treated with 6 mL of HNO3, 3 mL of HCl and 1 mL of H2O2 (Ultrapure Reagents, 
trace metal grade < 1 μg/L). The samples were processed by microwave digestion as follows: ramp to 200 
°C over 10 min, then hold at 200 °C for 20 min. After digestion, the samples were cooled to room 
temperature, filtered, transferred in a 50 mL volumetric flask and adjusted to 50 mL with distilled water 
for spectrometric analysis. The amount of Fol linked to the copolymer was quantified by UV-vis 
spectroscopy on DMSO polymer solutions (0.2-2 mg/mL), using Fol standard solutions in DMSO to 
construct calibration curves. The absorbance of the sample was evaluated at 360 nm on a Shimadzu 1800 
spectrophotometer. 
2.3 Synthesis of mPEGS-PCL and mPEGL-PCL  
Linear diblock copolymers were prepared by ring-opening polymerization (ROP) of CL at 120 °C for 
24 h using mPEGL or mPEGS as initiator and Sn(Oct)2 as catalyst (20%). CL/initiator molar ratio = 36. 
1
H 
NMR (CDCl3, δ in ppm), PCL block: 1.29–1.78 (m), 2.19–2.43 (t) 3.20 (m); 3.92–4.21 (t), 4.31(t); PEG 
block: 4.10 (t), 3.64 (s), 3.38, (t).  
2.4 Synthesis of Fol-PEG-PCL  
2.4.1 Synthesis of azido-PEG-PCL copolymer (N3-PEG-PCL) 
 Step 1. Synthesis of monotosyl-PEG (Ts-PEG-OH). PEG (5.00 g, 3.34 mmol) was dissolved in 50 mL 
of dry toluene. Ag2O (1.161 g, 5.01 mmol) and KI (110 mg, 0.668 mmol) were finely dispersed in the 
solution by stirring, then TsCl (2.76 g, 14.5 mmol) was added. The reaction mixture was kept at room 
temperature under stirring and nitrogen atmosphere for 12 h. The solution was filtered and solvent 
removed by rotary evaporation. The polymer was dissolved in 10 mL of DCM and precipitated in cold 
diethyl ether (yield 95%). 1H NMR (d6-DMSO, δ in ppm): 7.79 (2H, d), 7.49 (2H, d), 4.56 (1H, t), 4.11 
(2H, t), 3.49 (128H, s), 2.43 (3H, s). Step 2. Synthesis of monoazido-PEG (N3-PEG-OH). Ts-PEG-OH 
(1.00 g, 0.66 mmol) was dissolved in 15 mL of dry DMF, then NaN3 (214 mg, 3.3 mmol) was added and 
the mixture was stirred at 90 °C overnight under nitrogen atmosphere. The reaction mixture was cooled to 
room temperature, filtered, and DMF removed under vacuum. The product was dissolved in 10 mL of 
DCM and the solution was extracted twice with brine and twice with water in a separating funnel. The 
organic phase was dried over anhydrous Na2SO4, concentrated and poured in cold diethyl ether. Polymer 
was collected by filtration (yield 81%). 1H NMR (d6-DMSO, δ in ppm): 4.56 (1H, t), 3.6 (2H, t), 3.5 
(127H, s, PEG backbone), 3.4 (2H, t). FTIR diagnostic band: 2107cm-1 (N3 stretching). Step 3. Synthesis 
of N3-PEG-PCL copolymer. N3-PEG-OH (600 mg, 0.393 mmol), CL (1.572 g, 13.77 mmol) and Sn(Oct)2 
(31 mg, 0.078 mmol) were charged in a flask under dry nitrogen. The polymerization was carried out at 
120°C for 24 h under stirring. The copolymer was dissolved in 10 mL of DCM, precipitated in cold 
hexane, recovered by filtration and finally dried (yield 91%). 1H NMR (CDCl3, δ in ppm): 3.6 (2H, t), 3.5 
(127H, s, PEG backbone), 3.4 (2H, t), 1.29–1.78 (139H, m); 2.19–2.43 (82H, m), 3.92–4.21 (82H, t), 4.31 
(2H, t); Mn of PCL evaluated by 1H NMR = 4,6 kDa.  
2.4.2 Synthesis of propargylfolate 
Fol (500 mg, 1.13 mmol) was charged in a flask under dry nitrogen and dissolved by stirring in 20 mL 
of DMSO over mild heating, then DCC (446 mg, 2.16 mmol) and NHS (260 mg, 2.26 mmol) were added. 
Reaction was carried out in the dark at room temperature for 17 h, the solution was filtered to remove the 
side product (dicyclohexylurea, DCU), then propargylamine (124 mg, 2.25 mmol) and TEA (228 mg, 
2.25 mmol) were added. The reaction was left overnight. The product was precipitated with a 
diethylether/acetone 80/20 mixture, repeatedly washed first with acetone and then with diethylether, and 
finally dried under vacuum overnight. A yellow powder was obtained and analyzed by LC-MS (Agilent 
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Technologies, 6230 ESI-TOF) on a Phenomenex Jupiter column (C18, 3μm, 150x2.0 mm) with a gradient 
of acetonitrile (0.1% TFA) in water (0.1% TFA), from 5 to 50% in 15 minutes at a flow rate of 0.2 
mL/min.   
2.4.3 Click conjugation of propargylfolate with N3-PEG-PCL (Fol-PEG-PCL ) 
 N3-PEG-PCL (800 mg, 0.12 mmol) dissolved in 15 mL of DMSO was charged in a flask under dry 
nitrogen, then propargylfolate (86 mg, corresponding to a propargyl/N3 molar ratio of 1.1) and copper 
wires (120 mg) were added; the reaction was carried out under stirring at room temperature overnight. 
The solution was filtered to remove copper and then dialyzed against DMSO with a 2000 cut-off dialysis 
tube for 4 days, in order to eliminate free propargylfolate and other side products. Finally, DMSO was 
evaporated under nitrogen stream. The occurrence of reaction was confirmed by FTIR through the 
complete disappearance of 2097 cm-1 N3 stretching band (yield 95%). Fol content =6.5% by wt, 
functionalization degree=90%. 
2.5 Preparation and characterization of nanoparticles 
Non-targeted NPs were prepared from mPEGS-PCL and mPEGL-PCL while folate-decorated NPs were 
prepared from a mixture of mPEGS -PCL or mPEGL -PCL with Fol-PEG-PCL . NPs were formed by 
solvent diffusion of an organic phase (10 mg of copolymer in 1 mL of acetone) added dropwise in water 
(4 mL) under magnetic stirring (500 rpm). After solvent evaporation, NPs were filtered through 0,45 μm 
Phenex® filters (Phenomenex, USA). NPs could be freeze-dried (Modulyo Edwards) after the addition of 
HPβCD as cryoprotectant (polymer: HPβCD 1:10 wt. ratio, sample frozen in liquid N2, condenser 
temperature -55°C) and stored at 4 °C. Recovery yield of the production process was evaluated on an 
aliquot of NPs without cryoprotectant by weighing the solid residue after freeze-drying. To evaluate cell 
uptake, the lipophilic dye NR was physically entrapped (0.2% of copolymer weight). The hydrodynamic 
diameter (DH), polydispersity index (PI) and zeta potential (ξ) of NPs were determined on a Zetasizer 
Nano Z (Malvern Instruments Ltd).  
Fixed aqueous layer thickness (FALT) of NPs was measured by monitoring the influence of ionic 
strength on ξ. Different amounts of NaCl stock solutions were added to NPs dispersed in water (5 mg/mL, 
100 μl) and zeta potential of the samples measured. A plot of ln ξ against 3.33[NaCl]0.5 gives a straight 
line where the slope represents the thickness of the shell in nm.(Endres et al., 2011) 1H NMR was carried 
out on NPs dispersions to evaluate the amount of PEG on the surface. Spectra were recorded for either 
NPs prepared in D2O or NPs freeze–dried without cryoprotectant dissolved in d6-DMSO (5 mg/ml). 
Steady state fluorescence spectra were carried out with a RF6000 spectrofluorimeter (Shimadzu, Japan). 
Fluorescence lifetimes were recorded with Fluorolog-2 spectrofluorimeter (Model F111, Horiba) 
equipped with a TCSPC Triple Illuminator. The samples were irradiated by pulsed diode excitation source 
Nanoled at 370 nm. The kinetics were monitored at 450 nm nm and each solution itself was used to 
register the prompt at the excitation wavelength. The system allowed measurement of fluorescence 
lifetimes from 200 ps. The multiexponential fit of the fluorescence decay was obtained using the 
following equations:  
I(t) = 1exp(
-t/1
) + 2exp(
-t/2
). 
All measurements were performed in a thermostated quartz cell (1 cm path length, 3 mL capacity).  
Stability of NPs in the presence of HSA (1-500 M) was evaluated by placing a NPs sample (0.05 
mg/mL) in the HSA water solution and monitoring immediately the size distribution by PCS.  
2.6 Intracellular uptake of NPs in cancer cells 
KB carcinoma cells (American Type Culture Collection, ATCC, Rockville, USA) over-expressing FR 
(FRα) were selected to study the specific internalization of Fol-decorated NPs vs. non-targeted NPs. The 
cells were grown in Eagle’s medium (MEM) (Life Technologies) supplemented with 10% fetal bovine 
serum (FBS) (Gibco), 100 U/mL Penicillin G and 100 µg/mL Streptomycin and maintained at 37 
◦
C in a 
humidified atmosphere containing 5% CO2. Flow cytometry measurements of the uptake of DBLS, 
DBLS/DBL-Fol, DBLL, DBLL/DBL-Fol were performed using fluorescent NR-loaded NPs. For all the 
experiments mentioned above, cells were seeded in 24 wells/plate (40000 cells/well) in folate-deficient 
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RPMI medium (Life Technologies) supplemented with 10% FBS. After 24 h of growth at 37 
◦
C, the cells 
were incubated for 1 h with 20 µg/mL of NR-loaded NPs, freshly re-suspended in milliQ water and 
diluted in RPMI medium with or without 10% of FBS. After incubation with NPs, the cells were washed, 
detached from the plates with trypsin (Life Technologies), centrifuged and re-suspended in Versene 
before measuring NR fluorescence using a BD FACSCanto
TM
 II instrument (Becton Dickinson). The blue 
laser at 488 nm was used as excitation source and the PerCP channel (670–735 nm) was selected for the 
detection of NR fluorescence. 10
4
 events/sample were acquired and analysed with the FACSDiva 
Software. Competition experiments with 1 mM free Fol were carried out incubating the cells for 1 h prior 
to the addition of NPs in order to saturate FRs exposed on cell surface. The intracellular uptake of NR 
loaded DBLS and DBLS/DBL-Fol was measured also in A549 cells (ATCC), negative for FR expression. 
The cells were grown in F12-K medium (Life Technologies) supplemented with 10% FBS, 100 U/mL 
Penicillin G and 100 µg/mL Streptomycin. For the uptake experiments, cells were seeded as described 
above for KB cells and incubated for 1 h with NP formulations in the absence of serum in the incubation 
medium. 
To assess the endocytosis mechanism of DBLS/DBL-Fol NPs, KB cells were incubated 30 min before and 
during NP incubation (1 h) with specific molecules (all from Sigma) able to inhibit clathrin-mediated 
endocytosis (chlorpromazine hydrochloride, 5 µg/mL), caveolae-independent lipid-raft-dependent 
endocytosis (methyl-β-cyclodextrin, MβCD, 1 mM), caveolae-dependent endocytosis (Genistein 54 
µg/mL and Filipin III 5 µg/mL). 
The internalization of NPs in KB cells pre-incubated or not with 1 mM free Fol was assessed also by 
confocal microscopy using a SP5 laser scanning microscope (Leica Microsystems). 6 x 10
4
 cells were 
seeded in special tissue culture dishes for fluorescence microscopy (μ-Dish 35 mm, high, Ibidi GmbH), 
were allowed to growth for 24 h and then incubated for 1 h with 20 μg/mL NPs in medium added with 
10% FBS. After incubation, the cells were washed twice with PBS with Ca
2+
 and Mg
2+
 and immediately 
visualized under the microscope.  
2.7 Capture of NPs by human macrophages 
The capture by human macrophage of NPs decorated or not with Fol and pre-incubated in human 
serum (HS) was measured in order to assess their stealth properties. A positive control of non-PEGylated 
NPs (PCL) was tested too. Macrophages were derived from monocytes isolated from buffy coats of 
healthy donors by centrifugation over a Ficoll-Hypaque step gradient and subsequent Percoll gradient 
(Sigma-Aldrich). 2 x 10
6
 isolated monocytes/well were seeded in 24 wells/plate and cultured for 7 days in 
RPMI 1640 medium (Life Technologies) supplemented with 20% FBS and 100 ng/mL of human 
macrophage colony-stimulating factor (Peprotech) to promote macrophage differentiation. On day 4 from 
the seed, the macrophage colony-stimulating factor was added again. For the uptake experiment, 
macrophages were incubated for 3 h in RPMI added with 10% FBS and 20 µg/mL fluorescent NPs 
previously incubated at 37 °C in human serum type AB (Sigma-Aldrich) for 0, 10 or 30 min. 
Macrophages were then washed and detached from the plates using PBS with 5 mM EDTA, centrifuged, 
re-suspended in PBS + 1% BSA and analyzed by flow cytometry for fluorescence as described 
previously. Propidium Iodide (1 µg/mL) staining of the samples during flow cytometry acquisition was 
used to measure the macrophage viability, which was higher than 95%.  
2.8 Statistical analysis:  
The Primer software for biostatistics (McGraw-Hill, Columbus, USA) was used for statistical analysis 
of the data. The data are expressed as means ± SD of at least 3 independent experiments. The difference 
between groups was evaluated using the Student’s t-test considered significant for p < 0.05. 
 
3 Results and discussion 
3.1 Synthetic strategy 
PEG-PCL diblock copolymers with different PEG lengths were synthesized that is: i) Fol-PEG-PCL 
copolymer (PEG MW= 1.5 kDa); ii) mPEG-PCL with a PEG MW= 1.0 kDa (mPEGS-PCL); iii) mPEG-
PCL with a PEG MW= 2.0 kDa (mPEGL-PCL). Copolymers were synthesized by typical ROP 
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polymerization of ε-caprolactone using a mono-hydroxyl PEG as initiator. The molecular weight of PCL 
block was controlled by the CL/initiator molar ratio in the feed. A value of around 4.0 kDa was fixed for 
PCL on the basis of previous works (Conte et al., 2016; Tirino et al., 2014; Ungaro et al., 2012). 
 To prepare Fol-PEG-PCL copolymer, Cu(I)-catalyzed 1,3-Huisgen cycloaddition (“click” reaction) 
was chosen to conjugate folate to PEG-PCL (Himo et al., 2005). 1,3-Huisgen cycloaddition is the addition 
of alkynes to azides, with formation of highly stable 1,2,3-triazoles. The reaction is high yielding, 
stereospecific, does not create any byproduct, and can be conducted in mild conditions. PEG was first 
modified by introduction of an azide on one terminal group (Scheme 1). Synthetic strategies aimed to 
asymmetrically modify PEG are largely explored in the literature.In general, the reported methods suffers 
from a complex chemistry and/or low purity of the final product (Li and Chau, 2010; Szekely et al., 
2014). The most common way to synthesize heterotelechelic PEG remains polymerization of ethylene 
oxide from different initiators (Cammas et al., 1995; Hiki and Kataoka, 2007; Ishii et al., 2005; Raynaud 
et al., 2009; Thompson et al., 2008). To achieve monofunctionalization, the use of a large excess of PEG 
has been reported too (El-Gogary et al., 2014) although separation of non-modified from modified 
polymer requires tedious chromatography and yields are generally low. In the present paper, we used a 
method recently reported (Mahou and Wandrey, 2012) to achieve asymmetric activation of low molecular 
weight alcohols to low molecular weight PEG, so that it becomes possible to selectively link a 
biomolecule of interest to one end of PEG, and use the residual -OH for copolymerization. 
N3-PEG-OH is used as initiator for ring-opening polymerization of CL, leading to a PEG-azido 
functionalized copolymer. Azide is stable at the temperature required by ROP (120°C), as confirmed 
through FTIR analysis, where no change of diagnostic band of azide at 2097 cm
-1
 is detected in the 
copolymer spectrum. Mn of PCL block in the copolymers was calculated by the ratio between intensities 
of the resonance associated to–CH2–OH methylene protons at 3.64 δ and –CH2–CO– units in the PCL 
chain at 2.31 δ of 1H NMR spectrum. A good agreement between theoretical and experimental values is 
found (Table 1).  
In order to introduce the complementary alkyne group for successive coupling to N3-PEG-PCL, folic 
acid was conjugated with propargylamine through carbodiimide chemistry. It is known from the literature 
that only γ-folate conjugates retain affinity towards the receptor (Chen et al., 2013) Remarkably, γ-
conjugates are intrinsically obtained as the major product in reactions with carbodimide (Viola-Villegas et 
al., 2008); nevertheless, a clean product is hard to obtain, as separation of γ-conjugate from α- and bis-
conjugates and unreacted folic acid is troublesome. For this reason, it is critical to find reaction conditions 
under which formation of “clickable” α- and bis-conjugates is minimized. In this case, the crude product 
can be used as such for coupling with N3-PEG-PCL, then the final Fol-PEG-PCL copolymer will be 
easily separated from non-conjugated folic acid and other byproducts (i.e., activated folic acid, Fol-NHS) 
by dialysis (Liu et al., 2012). For purposes of optimization, a screening at different reaction conditions 
(type and amount of catalyst and propargylamine/catalyst molar ratio) was preliminary carried out, and 
products were characterized by LC-MS (Table S1, Fig. S1). Identification of α- and γ-conjugate peaks 
was made according to literature (Trindade et al., 2014). Conditions for -propargylfolate synthesis were 
set so that only a negligible amount of -conjugate and no bis-conjugate are formed (see Entry 1 of Table 
S1).  
In the click reaction, copper in form of wires was preferred as catalyst, since concentration of Cu(I) 
ions in solution is very low with respect to other catalysts type (Nahrwold et al., 2013), avoiding long 
purification steps. The total amount of crude propargylfolate was calculated in order to have a 
propargyl/N3 molar ratio corresponding to 1.1. Finally, the copolymer was easily purified by extensive 
dialysis to remove non-conjugated molecules. Reaction was followed by FTIR; the absence of azide band 
in the spectrum of Fol-PEG-PCL accounts for a 100% conversion (Fig. S2). For sake of accuracy, Fol-
PEG-PCL was analyzed by GPC-UV. The chromatogram shows a single peak at a retention time 
corresponding to that of pristine N3-PEG-PCL copolymer, confirming the absence of free folic acid 
and/or derivatives (Fig. S3). As a final check, the amount of residual copper in the copolymer, determined 
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by MP-AES analysis, was as low as 12 ppm, allowing to exclude any possible cytotoxic effect (Cao et al., 
2012). 
3.2 Influence of PEG length on nanoparticle shell 
We aimed at studying the effect of PEG length on the shell properties of folate-decorated NPs. To this 
purpose, NPs based on mixtures of Fol-PEG-PCL with either mPEGS-PCL (DBLS/DBL-Fol), where PEG 
is 1.0 kDa, or mPEGL-PCL (DBLL/DBL-Fol), where PEG is 2.0 kDa, were prepared (Fig. 1). We fixed 
Fol-PEG-PCL amount in the composition at 20% by wt based on the results obtained in a previous paper 
(Conte et al., 2016). Corresponding non-targeted NPs were prepared from mPEGL-PCL (DBLL) and 
mPEGS-PCL (DBLS). Solvent diffusion method, currently indicated as nanoprecipitation, was selected 
since it is very popular for preparing biodegradable NPs. Furthermore, solvent diffusion is a working 
principle in microfluidics, a process useful to increase the scale of NP production. 
As can be seen in Table 2, monodispersed NPs spontaneously form in good yield (around 60%) 
without the help of any surfactant. DBLL are smaller than DBLS likely due to higher hydrophilicity of 
mPEGL-PCL. A size lower than 100 nm as determined by dynamic light scattering and comprised in a 
narrow size range (PI<0.22) makes this formulation suitable for intravenous injection. ξ is slightly 
negative as commonly found for PEGylated NPs and slightly decreased for DBLS/DBL-Fol. NPs exhibit 
spherical morphology and preserve their shape once freeze-dried in the presence of HPβCD (Fig. S4, 
supplementary material). 
The amount of PEG on NPs surface was evaluated by 
1
H NMR and the packing extent of PEG on the 
surface calculated (Auguste et al., 2006; Xu et al., 2015). Results are reported in Table 2. For all the 
samples, the experimental amount of PEG on the surface is much lower than the theoretical value, 
suggesting that, in the conditions adopted to produce non-targeted and folate-targeted NPs, PEG is 
located inside NP core and partly confined to the surface. The amount of PEG on the surface decreases 
for DBLL (despite their low size) and more in general upon addition of folate copolymer. Furthermore, 
[Γ]/[Γ*] values well below the cut-off value of 1 indicate that PEG chains are in the mushroom-like 
conformation. These data demonstrate that, although NPs are prepared from PEGylated copolymers, the 
amount of PEG on the surface is below 7% in line with our previous results on triblock and star-shaped 
PEG-PCL copolymers (Ungaro et al., 2012). Similar degree of PEG coverage has been found preparing 
NPs by emulsion-solvent evaporation from mixtures of non-PEGylated and PEGylated copolymers (Xu et 
al., 2015). 
The thickness of the external shell of NPs was evaluated by FALT, measuring the values of NPs ξ in 
NaCl solutions at different concentrations and fitting the data to a regression line (r>0.980) (Fig. 2A). The 
slope of these lines in absolute value represents FALT in nm. FALT is lower for NPs prepared from 
DBLS with short PEG (2.51 ± 0.20 nm) and higher for NPs prepared from DBLL with long PEG (3.84 ± 
0.15 nm). In folate-decorated NPs, however, FALT increases for DBLS/DBL-Fol (2.72 ± 0.11 nm) and 
dectreases for DBLL/DBL-Fol (3.58 ± 0.29 nm) suggesting a different arrangement of folate in the shell. 
Folate folding in PEG chains on the surface is likely occurring for DBLL/DBL-Fol, which could hide 
targeting ligand on the surface and prevent receptor recognition. 
To gain insights into the environment experienced by folate moieties in the NPs, the emission 
behaviour of DBLS/DBL-Fol and DBLL/DBL-Fol was investigated by steady-state and time-resolved 
fluorescence spectroscopy. In fact, folate is a fluorescent molecule emitting in the visible range with an 
emission maximum at 450 nm. Fig. 2B shows the typical fluorescence emission of the folic acid, which is 
slightly more intense for DBLL/DBL-Fol. Inasmuch the two samples contain the same number of 
fluorogenic units, these slight but reproducible differences account for a larger fluorescence quantum 
yield for DBLL/DBL-Fol. In principle, this can be the result of i) self-quenching effects occurring in 
DBLS/DBL-Fol, ii) the different polarity experienced by the folate groups, or both. The dynamic behavior 
of the fluorescence is in line with the former hypothesis. As shown in Table 3, the fluorescence decay was 
bi-exponential in both cases. However, we observed a more pronounced contribution of the longer 
component in the case of DBLL/DBL-Fol. These finding are in fairly good agreement with a picture 
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involving the folate group of DBLS/DBL-Fol more exposed to water pool instead of being extended in the 
PEG shell.  
 
3.3 Interaction of nanoparticles with HSA  
Conformation of PEG on NPs surface can drive interactions with proteins. Here we focused on HSA, 
the most abundant protein in the blood pool. Interaction of NPs with HSA was clearly demonstrated by 
fluorescence spectroscopy. Fig. 3A shows the fluorescence spectra of HSA in the absence and in the 
presence of NPs upon excitation at 278 nm. This wavelength allows the selective excitation of HSA over 
folate. The black spectrum shows the typical dual band fluorescence spectrum of HSA, which reflects the 
contribution of the tyrosine (em ca 310 nm) and tryptophan (em ca 340 nm) fluorogenic centres. This 
strong emission is quenched by more than one order of magnitude upon addition of NPs. In contrast, the 
fluorescence of folate is basically unaffected in the presence of HSA (data not shown).  
Since the emission of HSA fluorescent aminoacids well overlaps with the absorption spectrum of the 
folate, one could explain the quenching observed as a result of a photoinduced energy transfer via FRET 
mechanism. However, this is not the case since no emission of the folate was in fact observed 
concurrently to the quenching. Rather, the fluorescence behaviour might be simply due to static 
quenching effects arising by the massive aggregation of HSA on the NPs.  
Formation of a HSA corona was evidenced also by evaluating size distribution curves of NPs at 
increasing HSA concentration (Fig. 3B). As compared to water, addition of HSA up to 5 μM does not 
change greatly the shape of the size curves, while at physiologically relevant HSA concentrations (500 
M) NPs mean size is increased for NPs of DBLL series and is unaltered for DBLS. The appearance of the 
peaks at 3 and 11 nm corresponding to free HSA monomers/tetramers/hexamers, indicate that in this 
adopted conditions, the surface of NPs is fully occupied by HSA. Remarkably, these results highlight that 
despite PEGylation, NPs developed here adsorb HSA forming a soft corona without inducing their 
aggregation. 
 3.4 Interaction of nanoparticles with human macrophages  
To predict NPs in vivo capture by mononuclear phagocyte system (MPS) once NPs are intravenously 
injected, we studied in vitro their uptake in human macrophages differentiated from monocytes and 
isolated from human buffy coats. Untargeted and folate-targeted NPs were not pre-incubated (time 0) or 
pre-incubated with human serum for 10 or 30 min at 37 °C before the addition and 3 h incubation with 
macrophages. A positive control of PCL NPs (non-PEGylated) was employed. Pre-incubation of NPs 
with human serum significantly increases their time-dependent uptake by macrophages for non-
PEGylated NPs only (Fig. 4), while the uptake of all the PEGylated NPs is unaffected or shows the 
opposite trend. Confirming a general paradigm, non-PEGylated NPs demonstrate the highest capture level 
by macrophages. The uptake of untargeted NPs increases when shortening the PEG length from 2.0 kDa 
to 1.0 kDa. In any case, the presence of folate on the surface does not affect significantly NPs 
phagocytosis. These results are in line with the general observation that the presence of a PEG shell on 
NPs surface limits the adsorption of serum proteins largely preventing NPs capture by phagocytes as 
macrophages (Walkey et al., 2012).  
 
3.5 Cellular uptake of nanoparticles in KB cancer cells 
To asses if the exposition of folate over the PEGylated surface increased the specific uptake of NPs in 
cells over-expressing FRs, we measured the uptake of targeted and non-targeted NPs in KB cells by flow 
cytometry. The uptake was measured in the absence and in the presence of 10% serum in the cell 
incubation medium to highlight the impact of NPs interaction with serum proteins. As reported in Fig. 
5A, the uptake of DBLS/DBL-Fol occurs at least in part through FR-mediated endocytosis. In fact, pre-
incubation of cells with 1 mM free Fol for 1 h to saturate FRs prior to NPs addition significantly 
decreases internalization. The extent of FR-mediated endocytosis of DBLS/DBL-Fol is higher without 
serum in the medium, probably due to partial ‘masking effect’ exerted by protein association to NPs shell 
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(Conte et al., 2016). On the contrary, although PEGylation degree is low and PEG is in a mushroom 
conformation for both DBLS/DBL-Fol and DBLL/DBL-Fol, only DBLS/DBL-Fol allows the recognition 
of folate moieties by FR in the presence of serum. For DBLL/DBL-Fol, folate amount is lower than 
expected on the basis of fluorescence lifetimes, and is probably unable to extend over the NPs surface 
because of the presence of a serum proteins corona. Flow cytometry (Fig. 5A) and confocal microscopy 
analysis (Fig. 5B,C) confirm the capability of DBLS/DBL-Fol to be taken up by KB cells with some 
selectivity, especially in the absence of serum. Microscopy images highlight a cytoplasmic and more in 
particular a perinuclear localization of DBLS/DBL-Fol with a clear decrease of fluorescence signal in the 
case of cells pre-incubated with free folate. 
On the contrary, in A549 cells negative for FR expression, flow cytometry experiments (Fig. S5) 
showed that the uptake of DBLS vs. DBLS/DBL-Fol was not significantly different (p > 0.05, t-test) even 
in the absence of serum in the incubation medium. Accordingly, in spite of a slight decreased NP uptake 
observed in competition experiments with an excess of free folate, this decreased uptake was not 
statistically relevant comparing DBLS and DBLS/DBL-Fol (p > 0.05, t test). 
 To gain more insight into the mechanism of DBLS/DBL-Fol uptake in KB cells we used drugs widely 
employed as inhibitors of specific endocytic pathways as clathrin-mediated endocytosis (chlorpromazine 
hydrochloride, CHL), lipid-raft-dependent endocytosis (methyl-β-cyclodextrin, MeβCD) and caveolae-
dependent endocytosis (Genistein, GEN and Filipin III, FIL). As reported in figure S6, MeβCD 
significantly lowered NP uptake (~ 80%), indicating that also the majority of NPs which did not enter the 
cells via FRs (~ 30%) were taken up exploiting lipid raft-dependent endocytosis. On the other hand, 
neither chloropromazine nor Genistein nor Filipin were able to inhibit DBLS/DBL-Fol NP uptake, 
indicating that clathrin-mediated and caveolae-dependent endocytosis were not involved in the cell 
internalization process.  
 
3.6 Modulating degree of valency in folate-decorated nanoparticles based on mPEGS-PCL 
As a final experiment, we prepared DBLS/DBL-Fol at different folate copolymer percentage (0-50% 
by wt of total copolymer) to understand if the amount of folate copolymer affected uptake in KB cells. 
Size distribution curves indicate that all the formulations are monodispersed (Fig. 6A) with a size below 
100 nm up to 30% of folate copolymer. A trend toward an increase of mean size and PI is observed for 
NPs at 50% Fol-PEG-PCL . All the NPs show a negative surface (ξ potential from -13 to -18 mV) as 
generally found for PEGylated NPs. As it can be seen in Fig. 6B, emission intensity of NPs is increased 
when increasing folate content whereas NPs of PEGS-PCL (without folic acid) do not exhibit any 
fluorescence signal. Furthermore, increase of Fol-PEG-PCL to 50% does not increase significantly NPs 
fluorescence, confirming that a fluorescence quenching is observed when the surface is more populated 
by folate moieties. Uptake studies in KB cells incubated with DBLS/DBL-Fol containing 10%, 20% or 
30% DBL-Fol polymers (Fig. 6C) demonstrated that, even in the presence of serum all the folate targeted 
formulations are taken up by cells via FRα-mediated endocytosis. Nevertheless, the extent of NPs 
accumulation through FRα-mediated endocytosis was comparable for all the formulations suggesting that 
an increase of folate amount in the NPs does not improve the extent of NPs intracellular accumulation. 
 
4 Conclusions 
Our study highlights that the too simplistic view of PEGylated NPs, both untargeted and targeted, is 
out to be close to the actual situation and needs to be elucidated if one wishes to correlate appropriately 
NPs properties to biological behaviour. We demonstrate that NPs prepared from diblock PEG-PCL 
copolymers by the widely employed solvent displacement method show a degree of PEGylation much 
lower than expected which depends on the length of PEG block. PEG acquires a mushroom conformation 
on NPs surface and its length affects the thickness of the hydrophilic shell as well as folate amount and 
exposition. HSA interacts with all NPs forming a protein corona which is not detrimental for stability. 
While all NPs show limited uptake in human macrophages, only the presence of short PEG (1.0 kDa) in 
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the copolymer ensures that folate-bearing NPs are accumulated in KB cancer cells via FRα-mediated 
endocytosis.  
This study offers a proof on how complimentary and simple techniques such as light scattering, 
fluorescence and NMR, can be employed to finely characterize the shell of targeted NPs with a 
PEGylated surface in the attempt to drive downstream effect such as NPs internalization in sub-set cell 
populations.  
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Table 1. Theoretical and experimental molecular weights of copolymers. 
 
Sample Mn (Da)
a
 Mn (Da)
b
 Mn (Da)
c
 Mw (Da)
c
 PDI
d
 (Mw/Mn) 
N3-PEG-PCL 5547 6203 5943 8049 1.36 
mPEGS-PCL 5047 5446 5059 6737 1.33 
mPEGL-PCL 6047 6579 6594 8720 1.35 
a 
Theoretical number-average molecular weight; 
b
 Number-average molecular weight evaluated by 
1
H NMR; 
c
 Molecular weight obtained by GPC; 
d 
Molecular weight polydispersity index obtained by 
GPC. 
 
 
Table 2. Properties of NPs prepared from short (DBLS) and long (DBLL) MPEG-PCL copolymers 
without and with Fol-PEG-PCL (DBL-Fol).  
Formulation 
 
DH 
a
 
(nm) 
PI ξ  
(mV) 
Surface 
PEG
b
 
(wt %) 
[Γ]c  
(chains/100 
nm
2
) 
[Γ]/[Γ*]d 
DBLS 78 ± 1 0.12 -13 ± 2 7.1 2.3 0.10 
DBLS/DBL-Fol 20 82 ± 4 0.11 -18 ± 2 4.2 1.4 0.07 
DBLL 34 ± 2 0.16 -15 ± 1 3.5 0.6 0.06 
DBLL/DBL-Fol 20 59 ± 5 0.22 -17 ± 3 2.0 0.6 0.05 
a
 The results are reported as mean of three separate measurements on three different batches 9) ± SD. 
b
 Surface PEG was 
measured by 
1
H NMR integrals of PEG signals in copolymer solution and in NPs. 
c
 [Γ] is the number of PEG chains per 
100 nm
2
 of nanoparticle surface area. 
d
 The ratio [Γ]/[Γ*] indicates packing extent of PEG on the surface. Values lower 
than 1 suggest a mushroom conformation. [Γ*] represents the theoretical number of unconstrained PEG chains that would 
occupy the nanoparticle surface.  
 
 
Table 3. Lifetimes (in ns) and amplitudes ( = 1) obtained 
by the biexponential fitting of the fluorescence decay for the 
different samples (ex= 370 nm em= 450 nm). 
Sample 1 1 2 2 
DBLS/DBL-Fol 20 0.50 0.30 7.71 0.70 
DBLL/DBL-Fol 20 0.63 0.22 8.00 0.78 
 
 
 
 
   
 
 
Scheme 1. Synthetic pathway for synthesis of N3-PEG-PCL diblock copolymer. Monofunctionalization of 
PEG was checked by 
1
H NMR analysis through the ratios between the intensities of -OH (4.56 δ) and –
CH2–O-Ts (4.11 δ) protons of PEG, and aromatic (7.79, 7.49 δ) and -CH3 (2.43 δ) protons of tosyl group 
(step 1). 
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Fig. 1. Design of untargeted and targeted NPs prepared from PEG-PCL diblock copolymers with different PEG 
length.  
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Fig. 2. Properties of the NPs shell. A) Thickness of the outer shell of non-targeted NPs (DBLS and DBLL) 
and targeted NPs (DBLS/DBL-Fol and DBLL/DBL-Fol). Shell thickness (in nm) can be derived from the 
absolute value of the slope in the regression lines. For clarity purpose, results of a single experiment are 
reported. B) Emission spectra of folate-decorated NPs (5 mg/mL) in water (λex= 370).  
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Fig. 3. Behavior of NPs in the presence of HSA. A) Emission spectra of folate-decorated NPs (5 mg/mL) 
in the presence of HSA (3 µM). A reference curve of a HSA solution (0.3 µM) is reported for 
comparison. Excitation wavelength was 278 nm. B) Size distribution curves of NPs (0.05 mg/mL) in the 
presence of HSA (1-500 µM). 
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 Fig. 4. NPs capture by macrophages. NPs were pre-incubated in human serum (HS) for 10 or 30 min 
before a 3 h incubation with macrophages at 37 °C. Phagocytosis Index represents the median total 
fluorescence intensity measured per macrophage by FACS. * p< 0.005, **p< 0.001 , with respect to NPs 
not pre-incubated with human serum (Student’s t-test). 
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Fig. 5. Intracellular uptake of NPs in KB cells over-expressing FRs. Flow cytometry measurements of the 
uptake of 20 µg/mL of Nile Red-loaded NPs (A). Cells were incubated with NPs for 1 h with or without 
10% serum in the medium and in the absence or the presence of 1 mM free folate (competition 
experiment). Significant different for *p<0.05, ***p<0.001, Student’s t-test. Confocal images of cells 
incubated with DBLS/DBL-Fol in the absence (B) or in the presence (C) of 1 mM free folate.  
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Fig. 6. Properties of DBLS/DBL-Fol NPs with different percentages of Fol-PEG-PCL . A) Size 
distribution curves. B) Emission spectra at λex 278 nm (NPs concentration was 5 mg/mL). C) Uptake of 
NR-loaded NPs (20 μg/mL) in KB cells after 1 h incubation in the presence and absence of FCS. 
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